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Abstract
The glial cell line-derived neurotrophic factor (GDNF) is a potent survival factor for several neuronal populations in different
brain regions, including the hippocampus. However, no information is available on the: (1) hippocampal subregions
involved in the GDNF-neuroprotective actions upon excitotoxicity, (2) identity of GDNF-responsive hippocampal cells, (3)
transduction pathways involved in the GDNF-mediated neuroprotection in the hippocampus. We addressed these
questions in organotypic hippocampal slices exposed to GDNF in presence of N-methyl-D-aspartate (NMDA) by
immunoblotting, immunohistochemistry, and confocal analysis. In hippocampal slices GDNF acts through the activation of
the tyrosine kinase receptor, Ret, without involving the NCAM-mediated pathway. Both Ret and ERK phosphorylation mainly
occurred in the CA3 region where the two activated proteins co-localized. GDNF protected in a greater extent CA3 rather
than CA1 following NMDA exposure. This neuroprotective effect targeted preferentially neurons, as assessed by NeuN
staining. GDNF neuroprotection was associated with a significant increase of Ret phosphorylation in both CA3 and CA1.
Interestingly, confocal images revealed that upon NMDA exposure, Ret activation occurred in microglial cells in the CA3 and
CA1 following GDNF exposure. Collectively, this study shows that CA3 and CA1 hippocampal regions are highly responsive
to GDNF-induced Ret activation and neuroprotection, and suggest that, upon excitotoxicity, such neuroprotection involves
a GDNF modulation of microglial cell activity.
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Introduction
Considerable interest has been devoted to neurotrophins as
candidate neuroprotective agents for several neurodegenerative
disorders since they promote neuronal survival, neuritic growth,
and differentiation of several, but selective, neuronal populations.
One such candidate is glial cell line-derived neurotrophic factor
(GDNF) given its spectrum of demonstrated activities which
includes, but is not limited to, potent trophic actions on a wide
variety of neuronal populations of the central and peripheral
nervous systems [1]. GDNF belongs to the GDNF family of
ligands which consist of four structurally related neurotrophic
factors - GDNF, neurturin, artemin , persephin- that signal
through a multicomponent receptor composed of the transmem-
brane receptor tyrosine kinase Ret (rearranged during transfection)
and high affinity glycosylphosphatidylinositol (GPI)-anchored
proteins, the GDNF family a receptors 1–4 (GFRa1–4). Despite
a cross-talk between the different ligands–GFRas pairs, a preferred
coreceptor molecule exists for each ligand, GDNF being the
preferred high-affinity ligand for GFRa1 [1,2].
In vitro studies have shown that following GDNF binding to
GFRa1 the resulting complex recruits Ret, leading to its activation
by dimerization and autophosphorylation at specific cytoplasmic
tyrosine residues, thus initiating a number of downstream
intracellular pathways [3]. On the other hand, a Ret-independent
pathway of GDNF signalling that involves the association of
GFRa-1 with the p140
NCAM isoform of the neural cell adhesion
molecule (NCAM) and subsequent activation of Fyn and FAK
kinases, has been as well demonstrated to take place in primary
glial cells and neurons [4,5].
In the last years a large number of studies demonstrated that
GDNF provides potent neuroprotection in animal models of
Parkinson’s disease [6], motor neuron degeneration [7,8], cerebral
ischemia [9], and limbic seizure [10]. More importantly, the
clinical use of GDNF for the treatment of the Parkinson’s disease
in humans is currently under evaluation [11]. The neuroprotective
role of GDNF in the above mentioned neurodegenerative diseases
lies on the widely recognized and potent pro-survival action on
midbrain dopaminergic neurons [12,13]; spinal cord motoneurons
[7,14,15], noradrenergic neurons of the locus coeruleus [16],
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forebrain [18], as well as peripheral sensory and autonomic
neurons [19]. Interestingly, GDNF may exert trophic actions also
in the hippocampus [20], a limbic region that is crucially involved
in learning and memory processes. In addition, this region exhibits
the distinctive feature of having neuronal populations which
display differential vulnerability to several neurodegenerative
stimuli [21]. Data obtained from in vivo studies indicated that
GDNF and its receptors are widely expressed in the rat
hippocampus [22–24]; furthermore, stroke, traumatic brain injury,
or kainate-induces seizures significantly increases GDNF and their
receptors mRNA expression in this limbic region [10,25]. In vitro,
GDNF has been found to protect hippocampal slice cultures and
primary cortical neurons against toxic activation of the N-methyl-
D-aspartate (NMDA) receptor [26,27], where its application
reduced the NMDA-induced calcium influx [27]. Although these
studies suggest an important role for this trophic factor in this
region following excitotoxic insults, the signalling pathways
involved in GDNF-mediated neuroprotection in each hippocam-
pal subfield and the identity of hippocampal cells that respond to
GDNF stimulation still remains elusive.
In the present study, by combining Western blotting, immuno-
fluorescence and confocal analysis on rat organotypic hippocam-
pal slice cultures (OHSCs), we first investigated the intracellular
signalling mechanisms triggered by acute or chronic GDNF
exposure in the different subfields of the hippocampus. Then, we
used the NMDA-induced neurotoxicity in OHSCs as experimen-
tal model to insight the neuroprotective actions of GDNF in the
different hippocampal subregions. Finally, we explored the identity
of hippocampal cells that respond to GDNF stimulation following
NMDA-induced neurodegeneration.
Results
GDNF stimulation activates Ret/ERK signalling in rat
organotypic hippocampal slices
With the aim to investigate the intracellular signalling
mechanisms triggered by GDNF stimulation of rat organotypic
hippocampal slices, we first tested the effect on ERK phosphor-
ylation in slice cultures at day of culture in vitro (DIV) 2, 7, and 14
following dissection. As shown in Fig. 1A and B, application of
GDNF under serum-free medium increased the phosphorylated
ERK levels with respect to the unstimulated slices, in a dose- and
time-dependent manner. Both concentrations of 100 ng/ml or
200 ng/ml of ligand were effective in causing a strong activation of
ERK at 30 minutes that was sustained up to 60 minutes. A return
to basal levels of ERK phosphorylation was observed following
24 h of GDNF application. Comparable results were obtained for
cultures from 2 (data not shown), 7 (Fig. 1A and B, left) and 14
DIV (Fig. 1A and B, right). In order to determine whether the
stimulation of phosphorylated ERK levels by GDNF treatment
was mediated by a Ret-dependent or by a p140
NCAM-dependent
mechanism, we stimulated hippocampal slices at 7 and 14 DIV
with 200 ng/ml GDNF for 30 minutes and looked for Ret and
FAK tyrosine phosphorylation, the latter being an upstream
effector of NCAM-dependent GDNF signalling [4]. As shown,
following GDNF stimulation, a marked increase in Ret phosphor-
ylation with respect to the basal levels was clearly observed
(Fig. 1C, upper panel, compare lanes 2 and 4 to lanes 1 and 3,
respectively and Fig. 1D), whilst no effect on FAK phosphorylation
was detectable (Fig 1C, middle panel), thus indicating that in
OHSCs GDNF signals mainly through Ret rather than through
the p140
NCAM-dependent, Ret-independent, pathway. Since both
the basal and GDNF-induced levels of Ret phosphorylation
(Fig. 1C, compare lane 3 to 1, and Fig. 1D) were higher in the
unstimulated slices from 14 DIV with respect to those from 7 DIV,
mature cultures at 14 DIV were used to perform the next
experiments.
GDNF activates Ret/ERK signalling in a specific
population of IB4-positive cells in the CA3 subregion
We thus determined the extent of Ret and ERK activation
following GDNF stimulation throughout the hippocampal sub-
fields. To this aim, we first exposed mature OHSCs to an acute or
chronic GDNF stimulation; the CA1 plus DG regions were
separated from the CA3 region and the crude extracts were
prepared and analysed by immunoblotting with anti-pRet or anti-
pERK antibodies. Following 30 minutes of GDNF treatment
(acute stimulation) a clear increase of both Ret and ERK
phosphorylation occurred essentially in the CA3 region (Fig. 2A,
compare lanes 4 to 2, and Fig. 2B-C). In addition, in control
serum-exposed slices the basal levels of Ret phosphorylation were
higher in CA3 if compared to CA1/DG and further increased by a
prolonged, chronic (48 h) GDNF treatment (Fig. 2D, compare
lane 4 to 2 and Fig. 2E-F).
As shown in Figure 2G-J, we further confirmed by immuno-
fluorescence analyses in HOSCs that the CA3 is the hippocampal
region that is more responsive to the action of GDNF. In fact,
acute GDNF stimulation induced a dense phoshorylated ERK
labelling specifically localized in the pyramidal layer of CA3
subfield (Fig. 2G-H). Although less intense and more diffuse, a
similar pattern of regional ERK phosphorylation in the CA3
subfield was observed under GDNF chronic stimulation in the
presence of serum (Fig. 2I-J).
Double immunofluorescence labelling with anti-pERK and
anti-pRet antibodies revealed the co-existence of both phosphor-
ylated Ret and pERK immunosignal of CA3 region of HOSCs
following acute GDNF stimulation (Fig. 3A-C). A large number of
cells in the pyramidal layer were double-labelled for both
phosphorylated ERK and Ret proteins (Fig. 3D-F).
In order to characterize the hippocampal cell population that is
responsive to GDNF we determined whether that population
might also be positive for IB4 labelling, a lectin that has been
recently used to identify a subpopulation of GDNF-responsive
neurons [28]. Co-localization experiments revealed that most of
the cells positive for pERK after GDNF stimulation in the CA3
region were double-labelled for IB4 (Fig. 3G-L). No co-localization
of pERK-positive cells with NeuN, GFAP, OX-42, Olig-2 or NF-
200 markers, which identify mature neurons, astrocytes, microglia
cell types, oligodendrocyte precursors and neurofilament proteins
of neuronal cells, respectively, was observed (data not shown).
These results, taken together, indicate that GDNF may induce Ret
activation and the consequent downstream signalling in a specific
population of hippocampal CA3 cells in the pyramidal layer that
are IB4-positive.
Neuroprotective effects of GDNF against NMDA-induced
neurodegeneration in rat organotypic hippocampal
slices
Given that the CA3 is the hippocampal subregion most
responsive to GDNF receptor activation, we determined whether
the neuroprotective action of GDNF was mainly exerted in this
region. As previously reported, exposure of rat OHSCs to 10 mM
NMDA resulted in a time-dependent enhancement of propidium
iodide (PI) uptake, that was detectable after at least 4–8 h of
NMDA exposure and was further increased after 24 and 48 h
[21]. When OHSCs were exposed for 48 h to 10 mM NMDA, cell
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PLoS ONE | www.plosone.org 2 August 2009 | Volume 4 | Issue 8 | e6486Figure 1. GDNF activates Ret/ERK signalling in rat OHSCs. (A) Slice cultures at DIV 7 (left) and 14 (right) following dissection were left
untreated (lanes 1 and 7) or stimulated with GDNF (100 ng/ml and 200 ng/ml) for the indicated incubation times. Crude extracts were
immunoblotted with anti-pERK antibodies and then the filters were stripped and reprobed with anti-ERK antibodies. To confirm equal loading the
filters were probed with anti-atubulin antibodies. Quantitations are done on the sum of the two ERK-specific enhanced chemiluminescence bands of
44 and 42 kDa. Intensity of bands have been calculated using the NIH Image Program on at least two different expositions to assure the linearity of
each acquisition. Fold values are expressed relative to the reference points (lanes 1 and 7), arbitrarily set to 1 (labelled with asterisk). (B) Plots of fold
values corresponding to the induction of pERK normalized for the amount of ERK in each lane of immunoblotting reported in A. (C) Slice cultures at
DIV 7 (left) and 14 (right) following dissection were left untreated or stimunlated with 200 ng/ml for 30 min. Crude extracts were immunoblotted
with anti-pRet and anti-pFAK antibodies. To confirm equal loading the filters were stripped and reprobed with anti-atubulin antibodies. Quantitations
are done on the sum of the two Ret-specific enhanced chemiluminescence bands of 170 and 150 kDa corresponding to different glycosylation states
of Ret. Fold values are expressed relative to controls (lanes 1 and 3), arbitrarily set to 1 (see A). (D) Plots of absorbance corresponding to the results
reported in C for Ret phosphorylation in the absence of GDNF (grey column), or in the presence of GDNF (black column), for both DIV 7 and 14. *
p,0.05 versus control group at 7DIV. ** p,0.05 versus all groups.
doi:10.1371/journal.pone.0006486.g001
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PLoS ONE | www.plosone.org 3 August 2009 | Volume 4 | Issue 8 | e6486Figure 2. Acute or chronic GDNF treatment activates Ret/ERK signalling preferentially in the CA3 region of OHSCs. Rat OHSCs (14 DIV)
were left unstimulated or treated with 200 ng/ml GDNF for 30 min (A) or 48 h (D); the CA1 plus DG regions were separated from the CA3 region and
the crude extracts were immunoblotted with anti-pRet or anti-pERK antibodies. Then the filters were stripped and reprobed with anti-ERK antibodies.
To confirm equal loading the filters were probed with anti-atubulin antibodies. Quantitations were done as reported in legend to Figure 1A and
relative abundances are expressed relative to CA1/DG regions (in the absence of GDNF stimulation), arbitrarily set to 1 (labelled with asterisk, lanes 1).
(B) and (E) Plots of absorbance corresponding to the results reported in A and D, respectively, for Ret phosphorylation (upper panel) and ERK
phosphorylation (lower panel). * p,0.05 versus CA1/DG control group. ** p,0.05 versus all groups (G-J) Distribution of pERK immunoreactivity in
control serum-free-exposed OHSCs for 30 minutes (G), in control serum-exposed OHSCs (I), in mature OHSCs exposed to acute (H) or to chronic -
GDNF exposure (J). Scale bar: 400 mm in G-J
doi:10.1371/journal.pone.0006486.g002
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to a lesser degree, in the CA3 and DG hippocampal subfields
(Fig. 4).
A marked neuroprotective effect was observed when GDNF was
added to the incubation medium 48 h before NMDA exposure
(Fig. 4). Shorter incubation times of GDNF were not sufficient to
exert such neuroprotective effects (data not shown). Cell death was
significantly reduced in all hippocampal subfields 24 h after NMDA
exposure (Fig. 4 panels A-C and G), whereas after 48 h of treatment
the CA1 and CA3 regions were the most sensitive regions to GDNF
induced neuroprotection (Fig. 4 panels D-F and H).
To verify whether GDNF prevention of NMDA-induced PI
uptake involved neuronal cell protection, immunohystochemical
analysis for the neuron-specific nuclear protein NeuN was
performed. Organotypic hippocampal slices exposed for 24 and
48 h to NMDA showed an evident loss of NeuN staining intensity
in CA1 and CA3 neurons (Fig. 5), that was rescued by GDNF
treatment. Interestingly,NeuNstaining intheCA1and, particularly
in the CA3 subfield of GDNF-treated OHSCs exposed to NMDA
was similar to controls (Fig. 5F-J), thus reinforcing the finding that
GDNF exerted a strong protective action on CA3 and CA1
neurons.
Ret receptor is activated in IB4-positive microglial cells of
hippocampal organotypic cultures pretreated with GDNF
and exposed to NMDA
Given the widespread observed neuroprotective actions of
GDNF against NMDA-induced neurodegeneration even in the
subregions that poorly respond to GDNF stimulation, (cfr Fig. 3),
we examined by immunoblotting the activation pattern of the Ret
receptor following NMDA insult in presence or in absence of
GDNF (Fig. 6A-B). To this aim, rat OHSCs were left untreated
Figure 3. Co-localization of pERK/pRet and of pERK/IB4 immunoreactivity in the CA3 region following acute GDNF exposure. (A-C):
Low magnification fluorescence microphotographs of OHSCs immunolabeled for pERK (green), and pRet (red) in the CA3 region. (D-F) Higher
magnification fluorescence images of the frame depicted in A-C displaying both pERK (green) and pRet (red) labelling in strata pyramidale of CA3
region. (G-I): Low magnification fluorescence microphotographs of OHSCs immunolabeled for IB4 (green), and pERK (red) in the CA3 region. (J-L):
Higher magnification of frames depicted in G-I displaying cells double-labelled for both pERK and IB4 signals (arrows) and a cells positive for pERK
only (arrowheads). Scale bars: 200 mm in A-C and G-I; 100 mm inD-F, 50 mm in J-L.
doi:10.1371/journal.pone.0006486.g003
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PLoS ONE | www.plosone.org 5 August 2009 | Volume 4 | Issue 8 | e6486Figure 4. Effect of GDNF during NMDA-induced neurotoxicity in rat OHSCs. (A-C): PI fluorescence staining patterns observed in
representative OHSCs 24 h following their exposure to the experimental conditions indicated in each panel. (D-F): PI fluorescence staining patterns
observed in representative OHSCs 48 h following their exposure to the experimental conditions indicated in each panel. Scale bar: 400 mm in A-F. (G-
H): quantification of cell damage (densitometric analysis of PI fluorescence) was performed in selected hippocampal subregions (CA1, CA3, DG). Data
are expressed as arbitrary units (A.U.) of PI fluorescence intensity. GDNF was used at the concentration of 200 ng/ml. Each data point is the
Mean6S.E.M. of the data obtained in 20–24 OHSCs from 3 separate experiments. Asterisks denote values statistically different from those obtained in
the respective NMDA-treated OHSCs (p,0.05).
doi:10.1371/journal.pone.0006486.g004
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the presence (lanes 5–6) of GDNF. When HOSCs were exposed to
NMDA for 24 h, Ret activation was observed in CA1/DG
subfields but not in the CA3 subregion (compare lane 3 to lane 1).
Twenty-four hours GDNF exposure of NMDA-exposed slices,
stimulated Ret phosphorylation in the CA3 region (compare lane
6 to lane 4 and 2) and further increased phosphorylated Ret
protein levels in CA1/DG subfield (compare lane 5 to lanes 1 and
3). In accordance with biochemical studies, immunofluorescence
staining performed with the anti-pRet antibody in the CA1
subregion revealed that pRet immunoreactivity increased in
presence of NMDA and was further pronounced in NMDA plus
GDNF-exposed slices. Interestingly, the anti-pRet antibody
intensely stained small and scattered cells throughout the slices
which resemble microglia cell populations. Consistently, double
immunolabelling experiments performed with pRet and both IB4,
or OX-42 (data not shown) microglial markers confirmed the
presence of pRet receptors on microglial cells either following
NMDA (data not shown) and NMDA plus GDNF exposed slices
(Fig. 6G-I). By contrast, pRet immunostaing was not evident in
microglia under control conditions (data not shown).
Discussion
In the present study, by using rat hippocampal organotypic
slices subjected to NMDA-induced neurotoxicity as model system,
Figure 5. GDNF neuroprotective effect on NMDA-induced cell death revealed by NeuN immunohistochemistry. A-E: NeuN
immunoreactivity in the CA1 pyramidal layer of control OHSC (A); NMDA-exposed HOSC for 24 h in absence (B) or in presence of GDNF (C); and of
NMDA-exposed HOSC for 48 h in absence (D) or in presence of GDNF (E). F-J: NeuN immunoreactivity in the CA3 pyramidal layer of control OHSC (F);
NMDA-exposed HOSC for 24 h in absence (G) or in presence of GDNF (H); and of NMDA-exposed HOSC for 48 h in absence (I) or in presence of GDNF
(J). K-O: NeuN immunoreactivity in the granule cell layer of dentate gyrus (DG) of control OHSC (K); NMDA-exposed HOSC for 24 h in absence (L) or in
presence of GDNF (M); and of NMDA-exposed HOSC for 48 h in absence (N) or in presence of GDNF (O). Scale bar: 50 mm in A-O. Quantification of
NeuN-positive cells in the CA1, CA3 and DG is reported. In each experimental group cells were counted in 9 non-overlapping microscope fields
subfields from three different slices. Data are expressed as percentage of NeuN-positive cells counted in control slices. *p,0.05 versus NMDA-
exposed HOSCs.
doi:10.1371/journal.pone.0006486.g005
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PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e6486Figure 6. GDNF-dependent Ret activation in OHSCs following NMDA exposure. (A) OHSCs were left untreated (lanes 1–2) or exposed to
NMDA in the absence (lanes 3–4) or in the presence (lanes 5–6) of GDNF for 24 h. Crude extracts were prepared from the CA1 plus DG regions and
from the CA3 region immunoblotted with anti-pRet antibodies. To confirm equal loading the filters were probed with anti-atubulin antibodies.
Quantitations were done as reported in legend to Figure 1A and relative abundances are expressed relative to CA1/DG control regions, arbitrarily set
to 1 (labelled with asterisk, lanes 1). (B) Plots of absorbance corresponding to the results reported in A for Ret phosphorylation. * p,0.05 versus
control and NMDA groups. ** p,0.05 versus all groups. C-I: Distribution of pRet immunoreactivity in mature OHSCs exposed to NMDA-induced
neurodegeneration in absence (C) or in presence of GDNF exposure (D). (E) Higher magnification of the frame depicted in D displaying intensely
stained pRet- positive cells scattered troughout the CA1 region. (F) Higher magnification of the frame depicted in E, displaying two cells (arrows) with
microglial morphology intensely labelled by the pRet antibody. G-I: Confocal microscopic images of OHSCs depicting microglial cells displaying both
pRet (red) and IB4 (green) immunoreactivity (thick arrows) in the CA1 region following NMDA plus GDNF exposure. Scale bars: 200 mm in C-D;
100 mm in E; 20 mm in F, 50 mm in G-I.
doi:10.1371/journal.pone.0006486.g006
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hippocampus.
Rat organotypic hippocampal slices express functional
GDNF receptor complex
First,wedemonstrated thatGDNFstimulationinducesactivation
of Ret tyrosine kinase receptor and its downstream effector ERK in
a dose and time dependent manner. By combining immunoblotting
and immunofluorescence experiments performed on separated
CA1, CA3 or DG subregions, we established that a GDNF
treatment either if rapid (30 min) or prolonged (48 h) induces a
strong activation of the Ret/ERK signalling preferentially in the
CA3 subfield. Recently, NCAM has been identified as an
alternative signalling receptor for GDNF [5]. Indeed, it has been
demonstrated that GDNF stimulates Schwann cell migration and
axonal growth in hippocampal and cortical neurons via binding to
p140
NCAM isoform in the presence of GFRa, but independently of
Ret, thus leading to activation of the cytoplasmic protein tyrosine
kinases Fyn and FAK, two signaling mediator downstream of
p140
NCAM [4]. In our experimental conditions, GDNF treatment of
OHSC did not activate FAK, thus indicating that in OHSC GDNF
doesn’t, or poorly, signals through the p140
NCAM-dependent
pathway.
In line with our results, in situ hybridization and immunohys-
tochemical experiments demonstrated that both Ret mRNA and
protein are much more abundant in CA2 and CA3 pyramidal
sector of rat postnatal [24], and adult human brain [29]. Despite
the GDNF-dependent activation of Ret was not addressed by these
studies, they suggest the involvement of Ret and GFRa receptors
signalling in processes fundamental for both the functional activity
and maintenance of the mature hippocampal neurons and the
organization of this cortical region during development.
Furthermore, with the attempt to elucidate the identity of
hippocampal cells that respond to GDNF stimulation, we found
activated both Ret and ERK proteins in a subpopulation of cells of
the pyramidal layer that by immunofluorescence co-localization
experiments with specific markers, NeuN, GFAP, OX-42, Olig-2
and NF-200 do not resemble neither mature neurons, astrocytes,
microglia, oligondendrocyte precursors nor neuronal cells. Intrigu-
ingly, these cells double-labelled for both phosphorylated ERK and
Ret proteins, resulted positive for the staining with IB4, a lectin that
although largely used as a marker for microglia [30], has been
recently reported to identify a subpopulation of GDNF-responsive
nociceptive dorsal root ganglion Ret-positive neurons [28,31,32].
GDNF protects CA3 and CA1 region against NMDA-
induced neurodegeneration
We found that GDNF displayed a broad neurotrophic action
following NMDA treatment that resulted in protecting, even if at
different degree, CA1 and the less vulnerable CA3 subfields.
Interestingly, we found that, while in the absence of the
excitotoxicity insult, GDNF stimulates Ret-dependent signalling
mainly in the subpopulation of IB4-positive cells of the CA3 region
(see above), the pattern of GDNF-dependent activation of Ret
changes following NMDA treatment. Indeed, we observed that a
pre-treatment of hippocampal slices with GDNF before inducing
the insult, caused a pronounced increase of Ret phosphorylation in
both CA1 and CA3 region. More specifically, we observed an
enhanced activation of Ret in IB4-positive microglial cells in the
CA1, and with a lesser degree in the CA3 region. In accordance
with our findings, it has been demonstrated that the GDNF
receptors, Ret and GFRa1, are expressed in rat primary cultured
microglia [33,34] and that exogenous GDNF administration may
not only have a protective effect on neurons, but may also have a
modulatory role in microglial activities including survival and
proliferation [33,35]. In fact, though microglial cells have been
reported to act as scavenger cells or mediator of inflammatory
responses in several neurodegenerative states, several studies
support a trophic role for these cells in tissue repair and
remodelling by secreting cytokines and/or growth factors [36].
Consistently with these observations, it can be hypothesized that
treating hippocampal slices with GDNF during the insult might
cause a regulation of microglial activities trough Ret activation,
thus providing trophic support in the most damaged CA1 region.
Collectively, this study shows that CA3 and CA1 hippocampal
regions are highly responsive to GDNF-induced Ret receptor
activation and neuroprotection, and suggest that, upon excitotox-
icity, such neuroprotective action involves a GDNF modulation of
microglial cell activity. Our results open new insights on the
mechanisms involved in the neuroprotective actions of GDNF.
Materials and Methods
Drugs and materials
Propidium iodide was from Molecular Probes Europe BV
(Leiden, The Netherlands). Recombinant GDNF was from
Alomone Labs (Jerusalem, Israel). All media and sera for OHSCs
were purchased from Gibco (Milan, Italy). NMDA was dissolved
directly in serum-free medium (stock solutions of 10 mM) and then
diluted to the desired concentration; this stock solutions was stored
at 4uC for 1 month. Stock solutions were diluted to achieve the
desired drug concentration immediately before use.
Rat organotypic hippocampal slice cultures
OHSCs were prepared as previously described in detail [21].
Briefly, 400 mm thick transverse hippocampal slices were prepared
from 7–9 days old Wistar rat pups (Charles River, Calco, Italy)
using a McIlwain tissue chopper (Campden Instruments, Leicester,
UK) in a sterile environment and placed into ice-cold HanKs’
balanced salt solution (HBSS, Gibco-BRL, Renfrewshire, UK)
supplemented with 5 mg/ml glucose and 1% (v/v) Fungizone
(Amphotericin B). Cultures were then transferred to humidified
semiporous membrane (30 mm Millicell-CM tissue culture plate
inserts of 0.4 mm pore size from Millipore, Rome, Italy) in 6-well
tissue culture plates (5 slices per membrane). Each well contained
1.2 ml of tissue culture medium consisting of 50% minimal
essential medium (MEM), 25% HBSS, 25% heat-inactivated horse
serum, 5 mg/ml glucose, 1 mM glutamine and 1% Fungizone; the
medium was replaced twice a week. OHSCs were mantained at
37
oC, 100% humidity, in a 95% air/5% CO2 atmosphere.
Experiments and animal use procedures were in accordance with
the National Institutes of Health guide for the care and use of
Laboratory animals (NIH Publications No. 8023, revised 1978);
the experimental protocol was approved by the Animal Care
Committee of the ‘‘Federico II’’ University of Naples.
Stimulation of OHSCs with GDNF
Cultures were exposed to GDNF in two ways. To examine the
acute effects of GDNF treatments in OHSCs we used the ‘‘drop
application’’, in which a 5 ml drop of 100–200 ng/ml GDNF
solution was applied to the top of each slice, as described by Marty
et al. [37]. This procedure has been show to accelerate the
penetration of neurotrophins [38]. Control slices received a drop
of the vehicle alone. To examine the chronic effects of GDNF
treatments in OHSCs, 200 ng/ml GDNF was included in the
culture medium beneath the membrane insert. The cultures were
exposed to GDNF for 48 h before inducing the neurotoxic insults.
GDNF Protection in CA1/CA3
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NMDA exposure was performed in OHSCs as previously
described [21]. OHSCs were removed from normal serum-
containing medium (NM), washed in serum-free medium (SFM,
consisting in NM with serum replaced with MEM) and exposed to
10 mM NMDA (with or without additional compounds) for 24–
48 h in fresh SFM. Control OHSCs were kept in SFM.
Assessment of cell death and image analysis
Cell injury was assessed using the fluorescent dye propidium
iodide. PI is a very stable and highly polar compound which only
enters cells with damaged or leaky plasmamembranes, binds to
DNA, and emits a brightly red fluorescence when exposed to blue-
green light. PIis non-toxic to neurons and has been used as a marker
of neuronal membrane integrity and cell damage. Briefly, at the
beginning of the experiment, 5 mg/ml PI was added to the culture
medium for 30 minutes to check for slice viability; OHSCs in which
significant PI fluorescence was detected were excluded from further
studies. PI uptake was recorded by a digital camera (Media
Cybernetics, Silver Springs, MD, USA) mounted on a Nikon
Eclipse 400 fluorescence microscope (Nikon Instruments, Florence,
Italy; excitation 510–560 nm, emission 590 nm). Preliminary tests
were carried out on maximally fluorescent OHSCs to determine a
combination of illumination intensity and integration time which
would fully exploit the 12-bit dynamic range of the imaging system
without saturating it. For densitometric measurements, the digital
photos were analyzed with the Image Pro-Plus software (Media
Cybernetics, Silver Springs, MD, USA), after freehand outlining of
the CA1,CA3 andDG neuronallayers,aspreviouslydescribed[21].
Western blotting experiments
In some experiments the slices were transferred to a glass slide at
ice temperature, and the CA3 areas were dissected out from CA1/
DG subregions under a stereo microscope and stored at 680uC
until assay. The slices were lysed in 50 mM Tris-HCl pH 8.0
buffer containing 150 mM NaCl, 1% Nonidet P-40, 2 mg/ml
aprotinin, 1 mg/ml pepstatin, 2 mg/ml leupeptin, 1 mM Na3VO4.
The solution was centrifuged at 16000 g for 30 min at 4uC and the
residue was discarded. Protein concentration was determined by
the Bradford assay using bovine serum albumin (BSA) as the
standard and the crude extracts were subjected to 10% SDS-
PAGE. Gels were electroblotted into polyvinylidene difluoride
membranes (Millipore Co., Bedford, MA), and filters were probed
with the indicated primary antibodies: anti-(Tyr1062-phosphory-
lated) Ret (indicated as pRet), anti-ERK1 (C-16) (Santa Cruz
Biotechnology Inc, Santa Cruz CA); anti-(Ser473-phosphorylated),
anti-phosphorylated-p44/42 mitogen-activated protein kinase E10
(indicated as pERK, Cell Signaling, Beverly, MA); anti-a-tubulin
(DM 1A; Sigma, St. Louis, MO); anti- (Tyr397-phosphorylated)
FAK (indicated as pFAK; Upstate, Lake Placid, NY). Proteins
were visualized with peroxidase-conjugated secondary antibodies
using the enhanced chemiluminescence system (Amersham-
Pharmacia Biosciences LTD, Uppsala, Sweden). When indicated,
membranes were stripped in 62.5 mM Tris-HCl pH 6.7, 0.1 M 2-
mercaptoethanol, 2% SDS for 30 min at 55uC.
Immunohystochemistry and immunofluorescence
confocal microscopy
Immunohistochemistry in OHSCs was performed as described by
Boscia et al. [39]. Briefly, OHSCs were washed in 0.1 M phosphate
buffer at pH 7.4 (PB) and fixed in 4% w/v paraformaldehyde an
0.1 M PB for 1 h at room temperature (RT). Slices were washed three
times in 50 mM Tris- buffered saline pH 7.4 (TBS) for 30 minutes
between each step. Slices were first blocked in 3% (w/v) BSA and
Triton X-100 0.25%, and then incubated with the following primary
antibodies: rabbit polyclonal anti-pERK (1:500; Cell Signaling, USA),
mouse monoclonal anti-pERK (1:1000, Cell Signaling, USA), rabbit
polyclonal anti-pRet (Tyr1062) (1: 200; Santa Cruz Biotechnology
Inc), mouse monoclonal anti-NeuN (1:2000; Chemicon, Milan, Italy);
Isolectin Bandeiraea Simplicifolia B4 (IB4) directly conjugated to FITC
(FITC-IB4; 1: 200; Sigma, Italy) at 4uC.
After 48 h, the slices processed for light microscopy were first
incubated in biotinylated horse anti-mouse or goat anti-rabbit IgG
(each at 1:200 dilution, Vector Laboratories, Burlingame, CA, USA)
for 2 h and then in avidin–biotinylated horseradish peroxidase
complex (Elite ABC, 1:300 dilution, Vector) for 1.5 h, always at room
temperature. The peroxidase reaction was developed using 3,3-
diaminobenzidine 4-HCl (DAB) as a chromogen and 0.05% H2O2.
After the final wash, sections were dehydrated, coverslipped, and
processed for microscope analysis. Images were acquired by a digital
camera (Coolsnap, Media Cybernetics, Silver Springs, MD, USA)
mounted on a Nikon Eclipse 400 microscope.
Following 48 h of primary antibody incubation, the slices
processed for single or double-labelling fluorescence experiments
were incubated in single or in a mixtures of fluorescent-labelled
secondary antibodies Alexa 488-conjugated anti-mouse IgG and
Alexa 568-conjugated anti-rabbit IgG (each at 1:200 dilutions;
Molecular Probes, Eugene, OR) for 3 h at RT. Finally, the
sections were washed in TBS, transferred onto microscope slides
and covered with Vectashield mounting medium (Vector Labo-
ratories, Inc., and California). Immunofluorescence images were
observed using a Zeiss LSM 510 META Laser-Scanning Confocal
Microscope (Carl Zeiss, Thornwood, NY, USA) by which single
images were taken with an optical thickness of 0.7 mm and a
resolution of 1,02461,024 pixels. Controls of the methods in the
present experiments included replacement of the primary antisera
with normal serum (1:200). To control for a possible cross-
reactivity between IgGs in double immunolabeling experiments,
some sections were processed through the same immunocyto-
chemical sequence except that primary antisera were replaced
with normal serum, or only one primary antibody was applied, but
the full complement of secondary antibodies was maintained. In
addition, the secondary antibodies utilized were highly pre-
adsorbed to the IgGs of numerous species. Tissue labelling
without primary antibodies was also tested to exclude autofluo-
rescence. No specific staining was observed under these control
conditions, thus confirming the specificity of the immunosignals.
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